Psoriasis Drugs Market Analysis, Segments, Growth and Value Chain 2017-2025

Psoriasis is an autoimmune disease characterized by red, itchy abnormal skin patches. There are five types of psoriasis: inverse, pustular, guttate, plaque, and erythrodermic. Psoriasis is considered to be a long-term skin disorder that produces plaques of scaling and thickened skin. The most commonly affected areas on the body are around the scalp, knees, navel, and back of the forearms. Psoriasis is triggered by various factors such as environmental factors and genetic deformity. Psoriasis is considered to be a non-curable disorder; however, a few drugs are available that ease the symptoms. Psoriasis therapies include topical therapeutic drug, systemic therapeutic drug, and combination of two or more therapies. A report published by the Alabama Pharmacy Association stated that around 17 million people in North America and Europe are affected by psoriasis. According to the treatment report, the frequency of occurrence of the disease is low in Africans, Americans, and Asians, and higher in Caucasians. According to a WHO report, males and females are almost equally affected. According to the WHO’s global report on psoriasis in 2016, the trends during 1979–2008 indicate that prevalence of psoriasis has increased from 4.8% to 11.4%.

Request Sample Copy of the Report @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=28487

The global gene gun market is expected to grow substantially due to the rise in recombinant DNA technology and genetic engineering. Increasing interest of scientists and researchers in this field and its varied application will drive the gene gun market as it plays a significant role in transformation experiments. Furthermore, advancements in agriculture, inclination toward genetically modified crops, and increasing research and development in the life science sector will fuel market growth. Rapid technological advancements in gene gun technology is anticipated to propel market growth during the forecast period. However, lack of sustained gene expression in target cell, death of the target tissue, and inaccuracy in the method may hamper the growth of the market. Also, altering with genetic makeup involves some ethical issues. These factors collectively may restrain the growth of the market in the near future.

The global gene gun market can be segmented on the basis of modality, applications, and geographical region. Gene guns are segmented on the basis of modality into portable handheld type, desktop type and others. With increasing recombinant DNA technology and genetic engineering, gene guns are finding extensive applications in agriculture, medical and other sectors. In agriculture, crops are genetically modified to improve their quality, nutritious value, reduce maturation time, develop resistance to pests, diseases, and herbicides, and to increase tolerance to harsh environmental conditions like extreme temperatures. In the medical field, gene gun technology has been used in vaccination as DNA vaccination and in other therapeutic applications.

Geographically, the gene gun market can be segmented into five major regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the gene gun market globally. This major share of the region is attributed to technological advancement and high quality research and development in genetic engineering which enables greater usage of the instrument. Asia Pacific is expected to be the rapidly growing market due to increasing research in genetic engineering and recombinant DNA technology and government funding supporting research in this field. Therefore, Asia Pacific and Latin America are lucrative target areas for major players of the gene gun market.

Key players in the gene gun market are Chintek Technology Co., Ltd, Bio-Rad Laboratories, Inc., Wealtec Corp., DuPont, Harvard Bioscience, Inc. (BTX), Thermo Fisher Scientific Inc. (Life Technologies Corporation), Ningbo Scientz Biotechnology Co., Ltd, and others.

Request TOC of the Report @ http://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=28487

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.